![]() |
Volumn 21, Issue 9, 2002, Pages 1309-1315
|
The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: A new anti-angiogenesis drug target
a
a
a
a
|
Author keywords
Cancer; Chromosomal translocation; Endothelium; Neo vascularization; Transcriptional regulation; Tumour angiogenesis
|
Indexed keywords
GENE PRODUCT;
LIM PROTEIN;
PROTEIN LMO2;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CHROMOSOME TRANSLOCATION;
CONTROLLED STUDY;
DRUG TARGETING;
FEMALE;
HUMAN;
LUNG TUMOR;
MALE;
MOUSE;
NEOVASCULARIZATION (PATHOLOGY);
NONHUMAN;
NUDE MOUSE;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
PROTO ONCOGENE;
SOLID TUMOR;
STEM CELL;
TERATOCARCINOMA;
THYMOMA;
TRANSCRIPTION REGULATION;
TUMOR GROWTH;
TUMOR VASCULARIZATION;
VASCULAR ENDOTHELIUM;
ANIMALIA;
MUS MUSCULUS;
|
EID: 0037148909
PISSN: 09509232
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.onc.1205285 Document Type: Article |
Times cited : (49)
|
References (23)
|